INSIGHTS ON DRUG DEVELOPMENT

• Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics

  Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.

• Navigating OSD Formulation Development And Leveraging CDMO Partnership

  Collaborating with an experienced CDMO can provide the expertise and facilities needed to navigate oral solid dose formulation complexities and ensure compliance with regulatory frameworks.

• Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed

  Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).

• Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics

  Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.

• The Importance Of Reliable Mixing In ITC Experiments

  5/1/2025

  Explore how Isothermal Titration Calorimetry (ITC) precisely analyzes molecular interactions, which provides crucial thermodynamic data to understand physiological processes and develop new therapeutic strategies.

• The History Of Microcalorimetry

  12/26/2023

  Here, we review the beginnings of calorimetry and microcalorimetry along with their modern history, applications, and use in biologics drug development.

• RSV Challenge Model For Anti-RSV Therapy

  3/27/2025

  Utilize advanced rodent models to accelerate the preclinical testing of your anti-RSV therapies and vaccines, advancing the fight against this widespread respiratory infection.

• AAV Empty/Full Ratio Assessment Using The Octet® AAVX Biosensors

  9/27/2024

  Learn about a rapid, high-throughput method for determining the E/F ratio in the AAV drug product that is well-suited for screening both crude and purified AAV samples.

• The Flux Performance Of Nanoformed And Untreated PRX Solid Suspensions

  7/26/2023

  Explore the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can characterize the membrane flux performance of an API formulated as a nanosuspension.